3:首次持股聲明-高管 JONES WILLIAM A JR
NewAmsterdam Pharma | 4:持股變動聲明-高管 Audet Juliette Berangere
NewAmsterdam Pharma | 4:持股變動聲明-董事 Topper James N
NewAmsterdam Pharma | 4:持股變動聲明-高管 Kastelein Johannes Jacob Pieter
NewAmsterdam Pharma | SC 13D/A:超過5%持股股東披露文件(修正)-BCLS Fund III Investments, LP(6.0%),BCLS II Investco, LP(5.4%)等
NewAmsterdam Pharma | 4:持股變動聲明-董事 LANGE LOUIS G
NewAmsterdam Pharma | SC 13D/A:超過5%持股股東披露文件(修正)-James N. Topper(14.2%),Patrick J. Heron(14.2%)等
NewAmsterdam Pharma | SC 13G/A:超過5%持股股東披露文件(修正)-RA Capital Management, L.P.(9.9%),Peter Kolchinsky(9.9%)等
NewAmsterdam Pharma | SC 13G/A:超過5%持股股東披露文件(修正)-Viking Global Investors LP(9.7%),Viking Global Opportunities Parent GP LLC(9.7%)等
NewAmsterdam Pharma | 3/A:首次持股聲明(修正)-高管 Davidson Michael H.
NewAmsterdam Pharma | 3/A:首次持股聲明(修正)-董事 LANGE LOUIS G
NewAmsterdam Pharma | 4:持股變動聲明-董事 Lewis William
NewAmsterdam Pharma | 3:首次持股聲明-董事 Lewis William
NewAmsterdam Pharma | 4:持股變動聲明-高管 Kooij Louise Frederika
NewAmsterdam Pharma | 4:持股變動聲明-高管 Kling Douglas F
NewAmsterdam Pharma | 4:持股變動聲明-董事 van der Kamp Hilde Johanna
NewAmsterdam Pharma | 4:持股變動聲明-董事 Smither John W
NewAmsterdam Pharma | 4:持股變動聲明-高管 Kastelein Johannes Jacob Pieter
NewAmsterdam Pharma | 4:持股變動聲明-董事 LANGE LOUIS G
NewAmsterdam Pharma | 4:持股變動聲明-高管 Davidson Michael H.
暫無數據